Chemoinformaics analysis of Methylisopelletierine
| Molecular Weight | 155.241 | nRot | 2 |
| Heavy Atom Molecular Weight | 138.105 | nRig | 7 |
| Exact Molecular Weight | 155.131 | nRing | 1 |
| Solubility: LogS | -0.5 | nHRing | 1 |
| Solubility: LogP | 0.586 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.2675 |
| nHD | 0 | BPOL | 19.6325 |
| QED | 0.601 |
| Synth | 2.706 |
| Natural Product Likeliness | 0.578 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.032 |
| HIA | 0.015 |
| CACO-2 | -4.467 |
| MDCK | 0.00000955 |
| BBB | 0.937 |
| PPB | 0.109958 |
| VDSS | 1.589 |
| FU | 0.885416 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.401 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.963 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.114 |
| CYP2d6-inh | 0.229 |
| CYP2d6-sub | 0.9 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.498 |
| CL | 9.011 |
| T12 | 0.77 |
| hERG | 0.046 |
| Ames | 0.016 |
| ROA | 0.568 |
| SkinSen | 0.773 |
| Carcinogencity | 0.735 |
| EI | 0.553 |
| Respiratory | 0.934 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.937814 |